FOLH1 and prostate carcinoma: Among 27 men undergoing screening for prostate cancer, 20 had both CTCs and PSA positivity, with prostate cancer detected via prostate specific-membrane antigen positron emission tomography (PSMA-PET) in 20/20 [24].